17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells

Ähnliche Einträge

• Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin inhibits the proliferation of ARPE-19 cells
  von: Wang Lin, et al.
  Veröffentlicht: (2010-04-01)
• Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin inhibits the proliferation of ARPE-19 cells
  von: Yao, Jia-Qi, et al.
  Veröffentlicht: (2010)
• Targeted inhibition of heat shock protein 90 disrupts multiple oncogenic signaling pathways, thus inducing cell cycle arrest and programmed cell death in human urinary bladder cancer cell lines
  von: Karkoulis Panagiotis K, et al.
  Veröffentlicht: (2013-02-01)
• Targeted inhibition of heat shock protein 90 disrupts multiple oncogenic signaling pathways, thus inducing cell cycle arrest and programmed cell death in human urinary bladder cancer cell lines
  von: Karkoulis, Panagiotis K, et al.
  Veröffentlicht: (2013)
• Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90
  von: Sydor, Jens R., et al.
  Veröffentlicht: (2006)